Actively Recruiting
Evaluating Single-Dose Baloxavir Marboxil Versus Placebo for Influenza Prevention in Household Contacts A Phase III Randomized, Double-Blind, Placebo-Controlled Study in Chinese Participants
Led by Hoffmann-La Roche · Updated on 2026-10-22
325
Participants Needed
8
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness of a single dose of baloxavir marboxil compared with a placebo for preventing influenza virus infection in people who live with someone diagnosed with influenza. This study focuses on household contacts of influenza patients and aims to reduce symptomatic, laboratory-confirmed influenza cases. It is a Phase III, randomized, double-blind, placebo-controlled trial involving participants aged 5 years and older. Participants who live with an influenza patient will receive either baloxavir marboxil or a matching placebo based on their body weight. The influenza patients themselves will not receive the study drug but will continue their usual standard of care treatment. The study uses a parallel design to compare outcomes between these groups during the prevention period. Throughout the study, participants will be monitored from Day 1 up to Day 10 for influenza infection confirmed by laboratory tests and symptoms such as fever and respiratory issues. Researchers will also track adverse events for up to 21 days. Participants will keep symptom diaries if age-appropriate, and COVID-19 testing will be performed to exclude those with infection. The study completion is expected by April 2027.
CONDITIONS
Brief Title
A Study to Confirm Efficacy of a Single Dose of Baloxavir Marboxil in the Post-exposure Prophylaxis (PEP) of Influenza Virus Infection in Chinese Participants
Research Team
R
Roche Pharma (Schweiz) AG Reference Study ID Number: YV46459, https://forpatients.roche.com/
F
Fastest response: use the inquiry form https://www.gene.com/contact-us/submit-medical-inquiry
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here